p53 Mutations and Prognosis in Bladder Tumors

Silverberg, 1990, Cancer Statistics--1990, CA, 40, 9

Japanese Health Welfare Statistics Association: Health and Welfare Statistics. Tokyo, Japan, vol. 38, p. 417, 1991.

Prout, 1979, Bladder carcinoma as systemic disease, Cancer, 43, 2532, 10.1002/1097-0142(197906)43:6<2532::AID-CNCR2820430654>3.0.CO;2-B

Vogelstein, 1988, Genetic alterations during colorectal-tumor development, New Engl. J. Med., 319, 525, 10.1056/NEJM198809013190901

Davidoff, 1991, Maintenance of p53 alterations through breast cancer progression, Cancer Res., 51, 2605

Baker, 1990, p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis, Cancer Res., 50, 7717

Takahashi, 1989, p53 a frequent target for genetic abnormalities in lung cancer, Science, 246, 491, 10.1126/science.2554494

Tsai, 1990, Allelic loss of chromosome 9, 11, and 17 in human bladder cancer, Cancer Res., 50, 44

Olumi, 1990, Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder, Cancer Res., 50, 7081

Sidransky, 1991, Identification of p53 gene mutations in bladder cancers and urine samples, Science, 252, 706, 10.1126/science.2024123

Fujimoto, 1992, Frequent association of p53 gene mutation in invasive bladder cancer, Cancer Res., 52, 1393

Habuchi, 1993, Influence of cigarette smoking and shistosomiasis on p53 gene mutation in urothelial tumor, Cancer Res., 53, 3795

Vogelstein, 1992, Carcinogens leave fingerprints, Nature, 355, 209, 10.1038/355209a0

Takahashi, 1991, The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern, Oncogene, 6, 1775

Morrison, 1984, An international study of smoking and bladder cancer, J. Urol., 131, 650, 10.1016/S0022-5347(17)50559-5

Hermanek, 1987

Mostofi, 1973

Uchida, 1993, Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma, J. Urol., 150, 1298, 10.1016/S0022-5347(17)35764-6

Uchida, 1993, Infrequent involvement of p53 gene mutations in the tumorigenesis of Japanese prostate cancer, Brit. J. Cancer, 68, 751, 10.1038/bjc.1993.423

Finlay, 1989, The p53 protooncogene can act as a suppressor of transformation, Cell, 57, 1083, 10.1016/0092-8674(89)90045-7

Mercer, 1991, Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression, Proc. Natl. Acad. Sci., 88, 1958, 10.1073/pnas.88.5.1958

Fields, 1990, Presence of a potent transcription activating sequence in the p53 protein, Science, 249, 1046, 10.1126/science.2144363

Sturzbecher, 1990, p53 interacts with p34cdc2 in mammalian cells: implications for cell-cycle control and oncogenesis, Oncogene, 5, 795

Gibas, 1984, Nonrandom chromosomal changes in transitional cell carcinoma of the bladder, Cancer Res., 44, 1257

Fearon, 1985, Loss of genes on the short arm of chromosome 11 in bladder cancer, Nature, 318, 377, 10.1038/318377a0

Ishikawa, 1991, Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas, Cancer Res., 51, 5736

Levine, 1991, The p53 tumour suppressor gene, Nature, 351, 453, 10.1038/351453a0

Soussi, 1990, Structural aspects of the p53 protein in relation to gene evolution, Oncogene, 5, 945

Hensel, 1991, Use of the single strand conformation polymorphism technique and PCR to detect p53 mutations in small cell lung cancer, Oncogene, 6, 1067

Reiter, 1993, Chromosome 17p deletions and p53 mutations in renal cell carcinoma, Cancer Res., 53, 3092

Okamoto, 1991, Frequent alleic losses and mutations of the p53 gene in human ovarian cancer, Cancer Res., 51, 5171

Sheffield, 1993, The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions, Genomics, 16, 325, 10.1006/geno.1993.1193

Coles, 1990, Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis, Lancet, 336, 761, 10.1016/0140-6736(90)93236-I

Saxena, 1992, Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas, Cancer Res., 52, 6716

Toguchida, 1992, Prevalence and spectrum of germ-line mutations of the p53 gene among patients with sarcoma, New Engl. J. Med., 326, 1301, 10.1056/NEJM199205143262001

Rideout, 1990, 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes, Science, 249, 1228, 10.1126/science.1697983

Horio, 1993, Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer, Cancer Res., 53, 1

Hamelin, 1994, Association of p53 mutations with short survival in colorectal cancer, Gastroenterology, 106, 42, 10.1016/S0016-5085(94)94217-X

Lipponen, 1993, Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value, Int. J. Cancer, 53, 365, 10.1002/ijc.2910530304